Ultrasound Predicts Advanced Liver Disease in CF Patients, According to Clinical Trial Data
Ultrasound may predict liver disease in young cystic fibrosis (CF) patients, according to the results of a clinical trial. Researchers...
AzurRx BioPharma Receives Sanction of Cystic Fibrosis Therapeutics Development Network for the Study
On track to initiate Phase 2 trial in cystic fibrosis patients in the fourth quarter of 2018 and conclude in 2019 NEW YORK, Nov. 01, 2018...
#NACFC2018 — Celtaxsys’ Acebilustat Delays Onset, Reduces Rate of Pulmonary Exacerbations in CF, Pha
Once-daily acebilustat, an investigational oral therapy for cystic fibrosis (CF) under development by Celtaxsys, reduces the frequency...
Corbus Awarded US Patent Covering Lenabasum as Potential CF and Fibrotic Disease Treatment
Corbus Pharmaceuticals has received a patent from the U.S. Patent and Trademark Office covering all compositions that comprise lenabasum...
Vertex and Treating CF: 3 Disease-modifying Therapies Make Leap from Lab to Patients
Editor’s Note: This is the second of a four-part series looking at Vertex Pharmaceuticals and its “all in for CF” approach. Here, we...
Vertex and Treating CF: Stepping Out on Long Road to ‘Medical History’
Editor’s note: This is the first of a four-part series looking at Vertex Pharmaceuticals and its “all in for CF” approach. We begin by...
MRSA Difficult to Eradicate, Even With Multimodal Antibiotics, CF Study Finds
Up to one month of treatment with inhaled vancomycin, the antibiotic of choice for treating most methicillin-resistant Staphylococcus...
DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Mana
- Opportunity for DarioHealth to take early lead in deploying digital health solution for this unique form of diabetes common in people...
IRT Test
Cystic fibrosis is caused by mutations in the CFTR gene, which results in thick mucus building up around organs and tissues. This is...
Acebilustat Seen to Prevent Pulmonary Exacerbations in CF Patients in Phase 2b Trial
Topline data from a Phase 2b trial showed that the investigative therapy acebilustat taken once daily can reduce the number and frequency...
